Dergiler / Turkish Journal of Biology / 2020 / Cilt: 44 - Sayı: 3

Gut-lung axis and dysbiosis in COVID-19

Sayfa
265–272
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Additionally, this review aims to clarify the ambiguity in fecal-oral transmission of SARS- CoV-2.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:COVID-19, a novel infectious disease, caused by SARS-CoV-2, affected millions of people around the world with a high mortality rate.
📊
Temel Bulgular & Veri:Although SARS-CoV-2 mainly causes lung infection, gastrointestinal symptoms described in COVID-19 patients and detection of the viral RNA in feces of infected patients drove attentions to a possible fecal-oral transmission route of SARS-CoV-2.
💡
Sonuç & Katkı:Additionally, this review aims to clarify the ambiguity in fecal-oral transmission of SARS- CoV-2.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

COVID-19, a novel infectious disease, caused by SARS-CoV-2, affected millions of people around the world with a high mortality rate. Although SARS-CoV-2 mainly causes lung infection, gastrointestinal symptoms described in COVID-19 patients and detection of the viral RNA in feces of infected patients drove attentions to a possible fecal-oral transmission route of SARS-CoV-2. However, not only the viral RNA but also the infectious viral particles are required for the viral infection and no proof has been demonstrated the transmission of the infectious virus particles via the fecal-oral route yet. Growing evidence indicates the crosstalk between gut microbiota and lung, that maintains host homeostasis and disease development with the association of immune system. This gut-lung interaction may influence the COVID-19 severity in patients with extrapulmonary conditions. Severity of COVID-19 has mostly associated with old ages and underlying medical conditions. Since the diversity in the gut microbiota decreases during aging, dysbiosis could be the reason for older adults being at high risk for severe illness from COVID-19. We believe that gut microbiota contributes to the course of COVID-19 due to its bidirectional relationship with immune system and lung. Dysbiosis in gut microbiota results in gut permeability leading to secondary infection and multiple organ failure. Conversely, disruption of the gut barrier integrity due to dysbiosis may lead to translocation of SARS-CoV-2 from the lung into the intestinal lumen via circulatory and lymphatic system. This review points out the role of dysbiosis of the gut microbiota involving in sepsis, on the severity of SARS-CoV-2 infection. Additionally, this review aims to clarify the ambiguity in fecal-oral transmission of SARS- CoV-2.

🔖

Bu Makaleye Atıf Yap

ASLIM, B., AKTAŞ, B. (2022). Gut-lung axis and dysbiosis in COVID-19. Turkish Journal of Biology, Cilt: 44 - Sayı: 3, 265–272. https://ajindex.com/articles/654390

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (2)

  1. Aleman FDD, Valenzano DR (2019). Microbiome evolution during host aging. PLoS Pathogens 15 (7): 21-24. doi: 10.1371/journal. ppat.1007727 Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY et al. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the USA 101 (44): 15718-15723. doi: 10.1073/pnas.0407076101 Bajaj JS (2019). Altered microbiota in cirrhosis and its relationship to the development of infection. Clinical Liver Disease 14 (3): 107-111. doi: 10.1002/cld.827 Bertók L (2004). Bile acids in physico-chemical host defence. Pathophysiology 11 (3): 139-145. doi: 10.1016/j. pathophys.2004.09.002 Burcelin R, Garidou L, Pomié C (2012). Immuno-microbiota cross and talk: The new paradigm of metabolic diseases. Seminars in Immunology 24 (1): 67-74. doi: 10.1016/j.smim.2011.11.011 Chen N, Zhou M, Dong X, Qu J, Gong F et al. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 395 (10223): 507-513. doi: 10.1016/S0140-6736(20)30211-7
  2. Chen Y, Chen L, Deng Q, Zhang G, Wu K et al. (2020). The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. Journal of Medical Virology 31: 1-8. doi: 10.1002/jmv.25825 D’Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L (2020). Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management. Clinical Gastroenterology and Hepatology. doi: 10.1016/j.cgh.2020.04.001 Darnell MER, Subbarao K, Feinstone SM, Taylor DR (2004). Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. Journal of Virological Methods 121 (1): 85-91. doi: 10.1016/j.jviromet.2004.06.006 Deitch EA (2012). Gut-origin sepsis: Evolution of a concept. Surgeon 10 (6): 350-356. doi: 10.1016/j.surge.2012.03.003 Dickson RP, Singer BH, Newstead MW, Falkowski NR, ErbDownward JR et al. (2017). Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nature Microbiology 1 (10): 16113. doi: 10.1038/ nmicrobiol.2016.113 Ding S, Liang TJ (2020). Is SARS-CoV-2 also an enteric pathogen with potential fecal-oral transmission: A COVID-19 virological and clinical review. Gastroenterology. doi: 10.1053/j. gastro.2020.04.052 Doig CJ, Sutherland LR, Sandham JD, Fick GH, Verhoef M et al. (1998). Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome